Katy Rezvani | Chief, Section of Cellular Therapy
MD Anderson Cancer Center

Katy Rezvani, Chief, Section of Cellular Therapy, MD Anderson Cancer Center

Dr. Rezvani is Professor of Medicine, Chief of Section of Cellular Therapy and Medical Director of the MD Anderson GMP and Cell Therapy Laboratory in the Department of Stem Cell Transplant and Cellular Therapy, MD Anderson Cancer Center. Dr. Rezvani has an active research laboratory program in transplantation immunology where the focus of her research group is to study the role of natural killer cells (NK) cells in mediating immunity against leukemia, and to understand the mechanisms of tumor-induced NK cell dysfunction. The goal of these studies is to develop strategies to enhance the activity of cord blood derived natural killer cells against tumors by genetically engineering the cells to enhance their in vivo antileukemic activity and persistence. Her laboratory program in transplant immunology has led to the approval and funding of a number of Phase I/II studies of immunotherapy in patients with leukemia and lymphoma.
 

Appearances:



Cord Blood Day 2- Thursday 17th May 2018 @ 14:30

Off-the-shelf CAR-engineered cord blood derived natural killer cells to treat cancer

  •     Discuss approaches for the GMP grade expansion of cord blood derived natural killer cells for cellular therapy
  •     Discuss strategies to engineer cord blood derived natural killer cells to enhance their anti-tumor potency and in vivo persistence 
  •     Present data on the first-in-human clinical trial of off-the-shelf CAR-engineered cord blood derived natural killer cells 

back to speakers

World Advanced Therapies & Regenerative Medicine Congress

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com